PharmaEssentia Corporation (TPE:6446)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
1,190.00
-50.00 (-4.03%)
Oct 30, 2026, 1:30 PM CST

PharmaEssentia Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, PharmaEssentia stock has a consensus rating of "Buy" and an average price target of $1,437. The average 1-year stock price forecast is 20.78% higher than the current stock price, while the lowest is $500.33 (-57.96%) and the highest is $2,143 (+80.08%).

Price Target: $1,437 (+20.78%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$500.33$1,437$1,510$2,143
Change-57.96%+20.78%+26.88%+80.08%

Analyst Ratings

The average analyst rating for PharmaEssentia stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy333444
Buy223333
Hold111111
Sell000000
Strong Sell000000
Total667888

Financial Forecast

Revenue This Year
27.07B
from 15.63B
Increased by 73.15%
Revenue Next Year
41.50B
from 27.07B
Increased by 53.31%
EPS This Year
26.88
from 12.25
Increased by 119.41%
EPS Next Year
43.95
from 26.88
Increased by 63.50%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
656.51M2.88B5.11B9.73B15.63B27.07B
Revenue Growth
17.81%339.00%77.15%90.67%60.61%73.15%
Gross Profit
277.65M2.07B4.50B8.56B13.95B24.74B
Gross Margin
42.29%71.82%88.04%87.91%89.23%91.38%
Operating Income
-2.82B-2.03B-1.91B1.74B4.93B12.56B
Net Income
-2.81B-1.37B-623.84M2.97B5.05B10.52B
EPS
----12.2526.88
EPS Growth
----69.83%119.41%
Forward PE
-69.0331.8941.3625.1644.27
Dividend / Share
---0.891.354.00
Dividend Growth
----51.32%195.81%
Free Cash Flow
----3.68B10.33B
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.

Revenue Forecast

Revenue202620272028
High29.6B
Avg27.1B
Low21.5B

Revenue Growth

Revenue Growth202620272028
High
89.3%
Avg
73.2%
Low
37.7%

EPS Forecast

EPS202620272028
High31.00
Avg26.88
Low23.71

EPS Growth

EPS Growth202620272028
High
153.0%
Avg
119.4%
Low
93.5%